Congresswoman Questions FDA Decision On Mentor Implant Study
This article was originally published in The Gray Sheet
Rep. Rosa DeLauro, D-Conn., is questioning FDA's decision in May to allow patients getting Mentor's MemoryGel silicone breast implant to opt out of the firm's 10-year post-approval safety study
You may also be interested in...
The chair of the House Appropriations Agriculture Subcommittee is threatening to zero-out salaries of FDA center directors and heads of offices in fiscal 2008 as a consequence of failing to follow through on safety investigations
FDA's Nov. 17 approval of silicone-gel breast implants comes with the requirement for one of the largest post-approval studies ever called for by the device center, according to CDRH Director Dan Schultz
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.